These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6228040

  • 1. [Evaluation of the mass vaccinal prevention of influenza in the Petrograd District of Leningrad].
    Mukhina LP, Rykushin IuP, Golubkova NB, Grin' VV, Belozerskikh NP.
    Tr Inst Im Pastera; 1982; 58():59-61. PubMed ID: 6228040
    [No Abstract] [Full Text] [Related]

  • 2. [Methodological approach to evaluating the vaccinal prevention of influenza as an epidemic control measure].
    Rykushin IuP, Mukhina LP.
    Tr Inst Im Pastera; 1982; 59():55-9. PubMed ID: 6228045
    [No Abstract] [Full Text] [Related]

  • 3. [Organization of mass vaccinal prophylaxis of influenza with inactivated chromatographic influenza vaccine in Leningrad].
    Dudarev AIa, Matiukhin NIa, Efimenko IB, Vasiutina EI, Kasatkin VV.
    Tr Inst Im Pastera; 1979; 52():59-61. PubMed ID: 162086
    [No Abstract] [Full Text] [Related]

  • 4. [Experience in the mass immunization of the working population of Leningrad with inactivated chromatographic influenza vaccine].
    Matiukhin NIa, Balabonova LB, Liamtseva GA, Efimenko IB, Evtukh NS.
    Tr Inst Im Pastera; 1982; 59():52-5. PubMed ID: 6228044
    [No Abstract] [Full Text] [Related]

  • 5. [Combined prevention of influenza using inactivated influenza vaccine and remantadine in organized collectives of adults].
    Malysheva AM, Ignat'eva GS, Erofeeva MK, Efremov BV, Maksakova VL.
    Tr Inst Im Pastera; 1982; 57():16-20. PubMed ID: 6221444
    [No Abstract] [Full Text] [Related]

  • 6. [Vaccinal prevention of influenza in children].
    Zykov MP, Vasil'eva RI.
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract] [Full Text] [Related]

  • 7. [Results of a 3-year survey of persons inoculated with inactivated influenza vaccine (IIV). I. An evaluation of its reactogenic peoperties, safety and epidemiological effectiveness].
    Mukhina LP, Kozlova NA, Rykushin IuP, Fridman EA, Bichurina MA.
    Tr Inst Im Pastera; 1979; 52():65-71. PubMed ID: 162088
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of mass influenza prevention effectiveness using an inactivated chromatographic vaccine in Leningrad].
    Ivannikov IuG, Efimenko IB, Marinich IG, Luk'ianov IuV, Naĭkhin AN.
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):18-27. PubMed ID: 6449811
    [Abstract] [Full Text] [Related]

  • 9. [Epidemiological effectiveness of inactivated influenza vaccine according to selective contingent observation data].
    Mukhina LP, Kozlova NA, Ershova ZA, Rykushin IuP, Fridman EA.
    Tr Inst Im Pastera; 1979 Nov; 52():61-5. PubMed ID: 162087
    [No Abstract] [Full Text] [Related]

  • 10. Epidemiological investigations in young children's communities concerning the efficiency of prophylactic immunization with inactivated influenza vaccine (I.C. 80) in a preepidemic season.
    Măgureanu E, Busuioc C, Ionescu V, Tisu A, Coban V, Stoicescu A, Guguianu E, Calomfirescu N, Bordeianu V, Toma C.
    Arch Roum Pathol Exp Microbiol; 1982 Nov; 41(3):233-8. PubMed ID: 7159214
    [No Abstract] [Full Text] [Related]

  • 11. [Results of a 3-year survey of persons inoculated with inactivated inflenza vaccine (IIV). II. The immunological effectiveness of IIV and its comparison with the epidemiological].
    Mukhina LP, Kozlova NA, Rykushin IuP, Bichurina MA, Polzik TP.
    Tr Inst Im Pastera; 1979 Nov; 52():71-5. PubMed ID: 162089
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The system of population protection against influenza.
    Shadrin AS, Karpukhin GI, Gararinova VM, Ivanova AS, Erophejeva MK, Efremov BV, Ignatjeva GS, Kustikova YuG, Maksakova VL, Turjeva AV.
    Z Erkr Atmungsorgane; 1985 Nov; 165(2):163-70. PubMed ID: 4082659
    [Abstract] [Full Text] [Related]

  • 14. [Experience in studying the effectiveness of influenza prevention].
    Nikitin VG.
    Vrach Delo; 1974 May; 5(0):139-41. PubMed ID: 4407770
    [No Abstract] [Full Text] [Related]

  • 15. Prevention and treatment of influenza infections.
    Iacuzio D.
    Adv Intern Med; 2001 May; 46():51-76. PubMed ID: 11147260
    [No Abstract] [Full Text] [Related]

  • 16. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [Abstract] [Full Text] [Related]

  • 17. Vaccination against influenza.
    Beare AS.
    Practitioner; 1975 Sep; 215(1287):315-9. PubMed ID: 1178625
    [No Abstract] [Full Text] [Related]

  • 18. [Uniqueness of the influenza epidemic situation in Leningrad in 1977-1978].
    Fridman EA, Briantseva EA, Maslennikova LK, Sapronova OA.
    Tr Inst Im Pastera; 1979 Sep; 52():18-22. PubMed ID: 162083
    [No Abstract] [Full Text] [Related]

  • 19. The burden of influenza and strategies for prevention.
    Belshe RB.
    Manag Care; 2007 Aug; 16(8 Suppl 8):2-6; discussion 17-9. PubMed ID: 17927016
    [No Abstract] [Full Text] [Related]

  • 20. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM, Keitel WA.
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.